When it comes to lowering skyrocketing drug prices, employers are making their voices heard on drug price transparency, drug price increase caps, and other price reducing strategies through the new coalition Employers' Prescription for Affordable Drugs (EmployersRx).
H.R. 3, a drug-price proposal from Democrats in Congress, would save taxpayers $345 billion over a seven-year period, according to a new estimate by the Congressional Budget Office. Read the story on Bloomberg >
Employers’ Prescription for Affordable Drugs uniting to advance competition, transparency and value WASHINGTON, D.C., October 09, 2019 – The Pacific Business Group on Health (PBGH), The ERISA Industry Committee (ERIC) and the National Alliance of
President Trump broke with most Republicans on Capitol Hill on the issue of drug pricing, saying on Twitter that it was “great to see” House Speaker Nancy Pelosi introduce a bill that many GOP lawmakers
Under proposed legislation from House Speaker Nancy Pelosi, government negotiations would be used as leverage to bring down the cost of certain high-cost drugs that have little competition. Read the story on Bloomberg Government >